Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Bevacizumab; Primary tumor resection;
مقالات ISI سرطان متاستاتیک کولورکتال (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سرطان متاستاتیک کولورکتال; Colorectal adenocarcinoma; Extrahepatic metastases; Hepatectomy; Liver and lung metastasis; Metastatic colorectal cancer;
Keywords: سرطان متاستاتیک کولورکتال; BB; bevacizumab-bevacizumab; BP; bevacizumab followed by panitumumab; CA9; carbonic anhydrase 9; CRC; colorectal cancer; DEGs; differentially expressed genes; EGFR; epidermal growth factor receptor; EPHA2; ephrin type-A receptor 2; FASN; fatty acid syntha
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; First-line chemotherapy; Duration of treatment; Maintenance treatment; De-escalated treatment; Cetuximab; Bevacizumab;
Keywords: سرطان متاستاتیک کولورکتال; Alternative endpoints; Duration of disease control; Maintenance; Metastatic colorectal cancer; Time to failure of strategy;
Keywords: سرطان متاستاتیک کولورکتال; Cost-effectiveness; Metastatic colorectal cancer; Precision medicine; Genetic mutation; Epidermal growth factor receptor;
Keywords: سرطان متاستاتیک کولورکتال; Laparoscopic surgery for colorectal cancer; Cytoreductive surgery; Metastatic colorectal cancer; Cirurgia laparoscópica para câncer colorretal; Cirurgia citorredutora; Câncer colorretal metastático;
Keywords: سرطان متاستاتیک کولورکتال; Low dose; Metronomic chemotherapy; Metastatic colorectal cancer; CRC; colorectal cancer; mCRC; metastatic colorectal cancer; MTD; maximal tolerated dose; PFS; progression-free survival; OS; overall survival; TSP-1; thrombospondin-1;
Keywords: سرطان متاستاتیک کولورکتال; Colorectal cancer; Surgery; liver metastasis; Preclinical; Clinical; Tumor growth; bFGF; basic fibroblast growth factor; CSC; cancer stem cell; CT; computed tomography; EMT; epithelial to mesenchymal transition; HCC; hepatocellular carcinoma; HGF; hepatoc
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Colorectal liver metastases; Unresectable; Conversion; Hepatectomy;
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; endpoint; quality of life; symptom control; survival;
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Primary tumour location; Sidedness; Prognostic biomarker; Predictive biomarker; Cetuximab; Panitumumab; Bevacizumab; Anti-EGFR; Anti-VEGF;
Keywords: سرطان متاستاتیک کولورکتال; ADCC; antibody-dependent cell-mediated cytotoxicity; AKT; protein kinase B; ATP; adenosine triphosphate; cfDNA; circulating free DNA; CISH; chromogenic in-situ hybridization; CTC; circulating tumor cells; EGFR; epithelial growth factor receptor; EMT; epit
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Randomized controlled trial; Chemotherapy; Monoclonal antibody;
Keywords: سرطان متاستاتیک کولورکتال; CDX-2; Chemotherapy; Metastatic colorectal cancer; Mutation; Overall survival; Prognosis;
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Beyond second line combination therapy; Regorafenib; Trifuridine/tipiracil; Reintroduction;
Keywords: سرطان متاستاتیک کولورکتال; Adolescent and young adults; Metastatic colorectal cancer; Real world; Treatment pattern; Young-onset CRC;
Keywords: سرطان متاستاتیک کولورکتال; Computed tomography; Metastatic colorectal cancer; Response assessment;
Keywords: سرطان متاستاتیک کولورکتال; Metastatic breast cancer; Metastatic colorectal cancer; Trastuzumab; Bevacizumab; Anthracycline; Cyclophosphamide; Paclitaxel; Irinotecan; Fluorouracil; Leucovorin;
Keywords: سرطان متاستاتیک کولورکتال; EGFR inhibitor; Meta-analysis; Metastatic colorectal cancer; VEGF inhibitor;
Keywords: سرطان متاستاتیک کولورکتال; Colorectal; Targeted therapy; Metastatic colorectal cancer; Molecular markers; Biologic therapy; mCRC; metastatic colorectal cancer; CRC; colorectal cancer; OS; overall survival; DFI; disease free interval; MSI; microsatellite instability; CTC; circulatin
Keywords: سرطان متاستاتیک کولورکتال; Adjuvant therapy; Combination therapy; Liver resection; Metastatic colorectal cancer; Surgery;
Keywords: سرطان متاستاتیک کولورکتال; elderly patients; metastatic colorectal cancer; third-line chemotherapy
Keywords: سرطان متاستاتیک کولورکتال; Brain metastasis; CNS metastasis; Metastatic colorectal cancer; Subgroups; Survival;
Keywords: سرطان متاستاتیک کولورکتال; Combination chemotherapy; Adjuvant therapy; Targeted therapy; First-line therapy; Metastatic colorectal cancer; Systemic therapy; Optimal sequence;
Keywords: سرطان متاستاتیک کولورکتال; Comorbidity; Elderly patients; Cetuximab; Irinotecan-pretreated; Metastatic colorectal cancer
Keywords: سرطان متاستاتیک کولورکتال; Carcinoembryonic antigen; Metastatic colorectal cancer; Monotherapy; Panitumumab; Response;
Keywords: سرطان متاستاتیک کولورکتال; Chemotherapy; Intra-arterial therapies; Metastatic colorectal cancer; Molecular targeted therapies; Multiline strategy;
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Liver-directed therapy; Synchronous lesions; Colorectal cancer liver metastases;
Keywords: سرطان متاستاتیک کولورکتال; Advanced colorectal cancer; Metastatic colorectal cancer; Monoclonal antibody; Bevacizumab; Cetuximab; Panitumumab; Targeted therapy; Health economics; Cost-effectiveness analysis; Cost-utility analysis;
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Irinotecan; Oxaliplatin; Cetuximab; Bevacizumab; Chemotherapy regimen sequencing; FOLFIRI; FOLFOX
Keywords: سرطان متاستاتیک کولورکتال; Cetuximab; Elderly; Metastatic colorectal cancer; Panitumumab; Review
A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer
Keywords: سرطان متاستاتیک کولورکتال; Angiogenesis; Apatinib; Chemotherapy; Metastatic colorectal cancer; Third-line therapy;
SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas
Keywords: سرطان متاستاتیک کولورکتال; Diagnostic biomarker; Metastatic colorectal cancer; Liver biopsy; SATB2;
A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis
Keywords: سرطان متاستاتیک کولورکتال; Comparative effectiveness; Meta-analysis; Metastatic colorectal cancer; Regorafenib; TAS-102;
Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS)
Keywords: سرطان متاستاتیک کولورکتال; Older patients; Metastatic colorectal cancer; Chemotherapy; Bevacizumab geriatric assessment;
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; RAS wild-type; Systemic chemotherapy; Sidedness; Meta-analysis;
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Resection; Conversion therapy; Cetuximab; Bevacizumab; Surgery;
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
Keywords: سرطان متاستاتیک کولورکتال; Fluoropyrimidine; Metastatic colorectal cancer; Randomised controlled trial; TAS-102; Tipiracil; Trifluridine;
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study
Keywords: سرطان متاستاتیک کولورکتال; Cetuximab; 5-FU; Oxaliplatin; mFOLFOX; Metastatic colorectal cancer;
A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer
Keywords: سرطان متاستاتیک کولورکتال; Advanced CRC; IXO regimen; Metastatic colorectal cancer; Phase 1; Triple combination;
Aflibercept Plus FOLFIRI in the Real-life Setting: Safety and Quality of Life Data From the Italian Patient Cohort of the Aflibercept Safety and Quality-of-Life Program Study
Keywords: سرطان متاستاتیک کولورکتال; Antiangiogenesis; Antivascular endothelial growth factor agents; HRQL; Metastatic colorectal cancer; Targeted therapy;
Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial
Keywords: سرطان متاستاتیک کولورکتال; AJCC; American Joint Committee on Cancer; AP; alkaline phosphatase; BRAF; v-Raf murine sarcoma viral oncogene homolog B; CI; confidence interval; CRC; (colorectal cancer); CT; computed tomography; ECOG; Eastern Cooperative Oncology Group scale of performa
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer
Keywords: سرطان متاستاتیک کولورکتال; Axitinib; First-line setting; Maintenance therapy; Metastatic colorectal cancer; Progression free survival;
A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumour
Keywords: سرطان متاستاتیک کولورکتال; Metastatic colorectal cancer; Primary tumour resection;
Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
Keywords: سرطان متاستاتیک کولورکتال; Colorectal cancer; Regorafenib; Protein-kinase inhibitors; Metastatic colorectal cancer; Systematic review;
Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response
Keywords: سرطان متاستاتیک کولورکتال; CRC; colorectal cancer; SIRT3; sirtuin 3; MSI; microsatellite instability; NRAS; neuroblastoma RAS viral oncogene homolog; BRAF; v-raf murine sarcoma viral oncogene homolog B; KRAS; Kirsten rat sarcoma viral oncogene homolog; PI3K; phosphatidylinositide 3
Emerging paradigms in the treatment of liver metastases in colorectal cancer
Keywords: سرطان متاستاتیک کولورکتال; CRC; colorectal cancer; mCRC; metastatic colorectal cancer; CLM; colorectal liver metastases; SR; surgical resection; PVE; portal vein embolism; RFA; radiofrequency ablation; APC; adenomatous polyposis coli; LOH; loss of heterozygosity; EGFR; epidermal gr
Clinical Features of Regorafenib-induced Liver Injury in Japanese Patients From Postmarketing Experience
Keywords: سرطان متاستاتیک کولورکتال; Adverse drug reaction; Drug-induced liver injury; Hepatotoxicity; Metastatic colorectal cancer; Real-world clinical practice;
Bispecific antibodies for cancer therapy: A review
Keywords: سرطان متاستاتیک کولورکتال; ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp